Isolation technology for research and development applications: from concept to production.

Area of Science:

• Pharmaceutical Manufacturing
• Sterile Product Development
• Containment Technology

Background:

• Traditional cleanroom technology presents challenges for sterile parenteral manufacturing.
• Research and Development (R&D) settings require flexible and reliable sterile production solutions.
• Isolator technology offers a contained environment for sterile operations.

Purpose of the Study:

• To design, construct, and commission a prototype parenteral manufacturing facility utilizing isolator technology.
• To validate the efficacy of vaporized hydrogen peroxide (VHP) for isolator sanitization.
• To assess the performance and suitability of the isolator-based facility for R&D sterile manufacturing.

Main Methods:

• Installation of closed isolators for sterile product handling and manufacturing.
• Evaluation of VHP distribution and sanitization effectiveness using chemical, biological, and swab testing.
• Performance qualification through media fills to demonstrate sterile process integrity.

Main Results:

• Established operating conditions for routine VHP sanitization of isolators.
• Media fills confirmed the sterile integrity of the manufacturing process, with identified handling deficiencies corrected.
• The isolator-based facility proved reliable and cost-effective for small batch sterile parenteral production.

Conclusions:

• Isolator technology provides a viable and economical alternative to cleanrooms for parenteral manufacturing in R&D.
• VHP sanitization is an effective method for maintaining aseptic conditions within isolators.
• While successful for small batches, closed isolator technology has limitations for large-scale automated production.